1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. OTC PROBIOTICS SUPPLEMENT MARKET BY FORM
5.1. Introduction
5.2. Capsules
5.3. Tablets
5.4. Powder & Syrups
6. OTC PROBIOTICS SUPPLEMENT MARKET BY INGREDIENTS
6.1. Introduction
6.2. Bacteria
6.2.1. Lactobacilli
6.2.2. Bifidobacterium
6.2.3. Streptococcus Thermophilus
6.3. Yeast
7. OTC PROBIOTICS SUPPLEMENT MARKET BY HEALTH AREA
7.1. Introduction
7.2. Gut Health
7.3. General Health
7.4. Immunity
7.5. Mental Well-Being
7.6. Others
8. OTC PROBIOTICS SUPPLEMENT MARKET BY DISTRIBUTION CHANNEL
8.1. Introduction
8.2. Online
8.3. Offline
9. OTC PROBIOTICS SUPPLEMENT MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Form
9.2.2. By Ingredients
9.2.3. By Health Area
9.2.4. By Distribution Channel
9.2.5. By Country
9.2.5.1. USA
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. South America
9.3.1. By Form
9.3.2. By Ingredients
9.3.3. By Health Area
9.3.4. By Distribution Channel
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.2. Argentina
9.3.5.3. Others
9.4. Europe
9.4.1. By Form
9.4.2. By Ingredients
9.4.3. By Health Area
9.4.4. By Distribution Channel
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.2. Germany
9.4.5.3. France
9.4.5.4. Spain
9.4.5.5. Others
9.5. Middle East and Africa
9.5.1. By Form
9.5.2. By Ingredients
9.5.3. By Health Area
9.5.4. By Distribution Channel
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.2. UAE
9.5.5.3. Others
9.6. Asia Pacific
9.6.1. By Form
9.6.2. By Ingredients
9.6.3. By Health Area
9.6.4. By Distribution Channel
9.6.5. By Country
9.6.5.1. China
9.6.5.2. Japan
9.6.5.3. India
9.6.5.4. South Korea
9.6.5.5. Taiwan
9.6.5.6. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. DuPont
11.2. Danone
11.3. Probi AB
11.4. Lifeway Foods, Inc.
11.5. Kibow Biotech
11.6. Pharmavite LLC
11.7. Osmotica Pharmaceuticals Corp
11.8. Dietary Pros, Inc.
11.9. Royal DSM
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations